Status:
UNKNOWN
Cancer Prevention in Women With a BRCA Mutation
Lead Sponsor:
Women's College Hospital
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
London Health Sciences Centre
Conditions:
BRCA1 Gene Mutation
BRCA2 Gene Mutation
Eligibility:
FEMALE
35-70 years
Phase:
PHASE1
Brief Summary
This study aims to develop a follow-up telephone-based genetic counselling (FTGC) intervention for women with a BRCA1 or BRCA2 mutation who have received genetic counseling in the past. Typically, whe...
Eligibility Criteria
Inclusion
- Confirmed BRCA mutation
- Age 35 to 70 years
- No previous bilateral salpingo-oophorectomy
- No previous or current ovarian cancer
- At least 12 months since genetic testing or most recent contact by Narod follow-up study
- Can speak and understand English
Exclusion
- Currently receiving treatment for another cancer diagnosis
- Pregnant
- Given birth in the last 6 months
- Booked surgical date for BSO
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02225015
Start Date
January 1 2015
End Date
June 1 2019
Last Update
June 9 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
London Regional Cancer Centre
London, Ontario, Canada, N6C 2R6
2
Women's College Hospital
Toronto, Ontario, Canada, M5S 1B1
3
Princess Margaret Hospital
Toronto, Ontario, Canada, M5T 2M9